See the PhD Opportunities section to see if this project is currently open for applications via MIBTP.
Please Note: The main page lists projects via BBSRC Research Theme(s) quoted and then relevant Topic(s).
How does copper increase antibiotic resistance and ability to cause infection?
Secondary Supervisor(s): Professor Joan Geoghegan
University of Registration: University of Leicester
BBSRC Research Themes:
Project Outline
Excess copper is highly toxic and forms part of the host innate immune system’s antibacterial arsenal, accumulating at sites of infection and acting within macrophages to kill engulfed pathogens.
All bacteria possess mechanisms to resist copper toxicity. The importance of bacterial copper resistance is evidenced by epidemic methicillin resistant Staphylococcus aureus (MRSA) acquisition of additional resistance mechanisms that confer copper-hyper resistance causing increased resistance to killing by macrophages and increased S. aureus infectivity.
Importantly our recent data show that subinhibitory copper functions as a regulatory signal, triggering coordinated transcriptional and metabolic remodelling that potentiates S. aureus fitness in the host. Copper alters expression of antibiotic resistance, virulence and immune evasion factors and alters the interaction of S. aureus with human epithelial cells.
Our hypothesis is that copper acts as an environmental signal to drive differential metabolic and physiological changes to potentiate S. aureus resilience to colonise multiple niches. However, the regulatory mechanisms involved and importance of copper homeostasis in clinical S. aureus carriage and disease isolates is unknown.
Aim is to:
- Identify the regulatory mechanisms critical for increased colonisation and antibiotic resistance.
- Determine importance of copper homeostasis mechanisms for clinical S. aureus isolates.
- Identify and explore novel therapeutic targets.
The methodologies used will include molecular microbiology, ‘omic analysis, human tissue culture and advanced imaging microscopy techniques. The team includes microbiologists, clinicians, and government agencies e.g UKHSA and Professor Joan Geoghegan, University of Birmingham. This is an exciting, inter-disciplinary project with environment and healthcare implications and opportunities.
Environ Microbiol. 20:1576-1589; MBio. 2018 9. pii: e00550-18; BIORXIV-2026-732922v1-Morrissey